highperformr logo

BioImagene's Overview

Total employees37
HeadquartersSunnyvale
Founded2003

BioImagene, Inc. was a prominent innovator in the field of digital pathology, providing comprehensive solutions including image analysis software, high-speed scanners for digitizing tissue slides, and workflow management systems. Founded in 1999, the company focused on transforming traditional pathology by enabling pathologists to view, manage, share, and analyze high-resolution digital images of tissue samples. This technology aimed to improve diagnostic accuracy, efficiency, and collaboration in cancer research and clinical settings. BioImagene was acquired by Roche in August 2010 for approximately $100 million, significantly enhancing Roche's portfolio in tissue-based diagnostics and contributing to the advancement of personalized healthcare.

Where is BioImagene's Headquarters?

HQ Function

The Sunnyvale headquarters served as the core for BioImagene's research and development, software engineering, corporate strategy, marketing, and administrative operations for its digital pathology solutions.

Notable Features:

As a cutting-edge technology firm, the facility likely included specialized R&D labs for developing imaging hardware and pathology software, alongside modern office spaces designed to foster collaboration and innovation.

Work Culture:

The work culture at BioImagene was likely dynamic and innovative, characteristic of a Silicon Valley tech company in the competitive medical technology sector. It would have emphasized scientific rigor, engineering excellence, and a fast-paced environment focused on disrupting traditional pathology practices.

HQ Significance:

This headquarters was crucial as the innovation hub where BioImagene developed its pioneering digital pathology technologies, contributing significantly to the early advancements in digitizing tissue diagnostics globally.

Values Reflected in HQ: The headquarters would have embodied values of innovation, precision in diagnostics, technological advancement, and a commitment to improving healthcare outcomes through digital solutions.

Location:

Before being acquired by Roche, BioImagene had established a growing global presence. Its operations were anchored by its headquarters in California and a major R&D and software development center in Pune, India. The company actively marketed and supported its digital pathology systems to laboratories, hospitals, and research institutions in North America, Europe, and parts of Asia, aiming to revolutionize pathology workflows worldwide.

Street Address:

760 N. Mary Ave

City:

Sunnyvale

State/Province:

CA

Country:

USA

BioImagene's Global Presence

Pune, Maharashtra/India

Address: Plot No. 20, Rajiv Gandhi Infotech Park, Phase-I, MIDC, Hinjewadi, Pune 411057, India (representative address)

This office played a key role in cost-effective product development and provided a base for potential expansion into Asian markets, supporting global operations with its technical expertise.

Buying Intent Signals for BioImagene

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of BioImagene

As of April 2025, BioImagene' leadership includes:

Dr. Arvinder S. Uberoy - Founder, President & CEO
Mohan Uttarwar - Co-founder & Chief Technology Officer
Dr. Ajit Singh - Chairman of the Board (at time of acquisition)
John M. W. Krelle - Chief Financial Officer (at one point)

Investors of BioImagene

BioImagene has been backed by several prominent investors over the years, including:

Nexus Venture Partners
Ventana Medical Systems
Kaiser Permanente Ventures
CLSA Capital Partners
EDBI Singapore
Agilent Technologies

Executive New Hires/Exits in the Last 12 Months

Hire0
Exits0

BioImagene was acquired by Roche in August 2010. Consequently, there have been no executive new hires or exits for BioImagene as an independent entity in the last 12 months or any recent period. Leadership changes occurred at the time of and subsequent to the acquisition as part of its integration into Roche.

Technology (Tech Stack) used by BioImagene

Discover the tools BioImagene uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

BioImagene Email Formats and Examples

Prior to its acquisition by Roche, BioImagene likely used standard corporate email formats for its employees. While not definitively documented publicly now, common formats included [first_initial][last]@bioimagene.com or [first].[last]@bioimagene.com. The domain 'bioimagene.com' now redirects to Roche.

[first_initial][last]@bioimagene.com (e.g., jdoe@bioimagene.com) or [first].[last]@bioimagene.com (e.g., jane.doe@bioimagene.com)

Format

jsmith@bioimagene.com

Example

0 (The bioimagene.com domain is no longer independently active for email)%

Success rate

News and media

Roche News CentreAugust 24, 2010

Roche Acquires BioImagene, Inc. to Strengthen Leadership in Tissue-Based Cancer Diagnostics

Roche announced its acquisition of BioImagene, Inc., a privately-held company based in Cupertino, California, for approximately $100 million. BioImagene was recognized as a leader in digital pathology, offering innovative image analysis solutions critical for cancer diagnostics....more

PR NewswireMarch 16, 2009

BioImagene Secures $15 Million Series C Funding to Accelerate Growth in Digital Pathology Market

BioImagene announced the completion of a $15 million Series C financing round. The funding, led by existing investors like Nexus Venture Partners and new participation from CLSA Capital Partners, was aimed at accelerating the company's growth and market adoption of its digital pathology solutions....more

FierceBiotechJuly 14, 2008

BioImagene inks digital pathology deal with Agilent

BioImagene entered into a strategic partnership with Agilent Technologies to co-market digital pathology solutions. This collaboration aimed to combine BioImagene's imaging systems with Agilent's reagents for pathology labs, enhancing research and diagnostic capabilities....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including BioImagene, are just a search away.